Cargando…

Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats

BACKGROUND: Associating liver partition and portal vein ligation (ALPPS) technique is a promising strategy for unresectable primary liver tumours without sufficient future liver remnants (FLRs). OBJECTIVE: Our study explored the effect of corosolic acid (CA) on inhibiting tumour growth without compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jinwei, Zhao, Weiyi, Xu, Hongyue, Luan, Wenjing, Wang, Xuefei, Fang, Yimu, Yu, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067999/
https://www.ncbi.nlm.nih.gov/pubmed/35481406
http://dx.doi.org/10.1080/07853890.2022.2067893
_version_ 1784700134885425152
author Zhao, Jinwei
Zhao, Weiyi
Xu, Hongyue
Luan, Wenjing
Wang, Xuefei
Fang, Yimu
Yu, Lu
author_facet Zhao, Jinwei
Zhao, Weiyi
Xu, Hongyue
Luan, Wenjing
Wang, Xuefei
Fang, Yimu
Yu, Lu
author_sort Zhao, Jinwei
collection PubMed
description BACKGROUND: Associating liver partition and portal vein ligation (ALPPS) technique is a promising strategy for unresectable primary liver tumours without sufficient future liver remnants (FLRs). OBJECTIVE: Our study explored the effect of corosolic acid (CA) on inhibiting tumour growth without compromising ALPPS-induced liver regeneration. METHODS: The ALPPS procedure was performed in Sprague–Dawley rats with orthotopic liver cancer. Blood, tumour, and FLR samples were collected, and the effect of CA on the inhibition of tumour progression and ALPPS-induced liver regeneration, and its possible mechanism, were investigated. RESULTS: The tumour weight in the implantation/ALPPS group was higher than in the implantation without ALPPS group (p < .05), and the tumour weight in the implantation/ALPPS/CA group was lower than in the implantation/ALPPS group (p < .05). On postoperative day 15, the hepatic regeneration rate, and the expression of Ki67+ hepatocytes in the FLRs had increased significantly in the group that underwent ALPPS. The number of cluster of differentiation (CD) 86+ macrophages markedly increased in the FLRs and in the tumours of groups that underwent the ALPPS procedure. Additionally, the number of CD206+ macrophages was higher than the number of CD86+ macrophages in the tumours of the implantation and the implantation/ALPPS groups (p < .01, respectively); however, the opposite results were observed in the CA groups. The administration of CA downregulated the expression of transforming growth factor-beta (TGF-β), CD31, and programmed cell death protein 1 (PD-1) but increased the number of CD8+ lymphocytes in tumours. CONCLUSION: KEY MESSAGES: This study aimed to investigate the effect of CA on ALPPS-induced liver regeneration and hepatic tumour progression after ALPPS-induced liver regeneration. Corosolic acid inhibits tumour growth without compromising ALPPS-induced liver regeneration. This result may be attributed to the CA-induced downregulation of PD-1 and TGF-β expression and the increased CD8+ lymphocyte infiltration in tumour tissue associated with the suppression of M2 macrophage polarisation.
format Online
Article
Text
id pubmed-9067999
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-90679992022-05-05 Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats Zhao, Jinwei Zhao, Weiyi Xu, Hongyue Luan, Wenjing Wang, Xuefei Fang, Yimu Yu, Lu Ann Med Oncology BACKGROUND: Associating liver partition and portal vein ligation (ALPPS) technique is a promising strategy for unresectable primary liver tumours without sufficient future liver remnants (FLRs). OBJECTIVE: Our study explored the effect of corosolic acid (CA) on inhibiting tumour growth without compromising ALPPS-induced liver regeneration. METHODS: The ALPPS procedure was performed in Sprague–Dawley rats with orthotopic liver cancer. Blood, tumour, and FLR samples were collected, and the effect of CA on the inhibition of tumour progression and ALPPS-induced liver regeneration, and its possible mechanism, were investigated. RESULTS: The tumour weight in the implantation/ALPPS group was higher than in the implantation without ALPPS group (p < .05), and the tumour weight in the implantation/ALPPS/CA group was lower than in the implantation/ALPPS group (p < .05). On postoperative day 15, the hepatic regeneration rate, and the expression of Ki67+ hepatocytes in the FLRs had increased significantly in the group that underwent ALPPS. The number of cluster of differentiation (CD) 86+ macrophages markedly increased in the FLRs and in the tumours of groups that underwent the ALPPS procedure. Additionally, the number of CD206+ macrophages was higher than the number of CD86+ macrophages in the tumours of the implantation and the implantation/ALPPS groups (p < .01, respectively); however, the opposite results were observed in the CA groups. The administration of CA downregulated the expression of transforming growth factor-beta (TGF-β), CD31, and programmed cell death protein 1 (PD-1) but increased the number of CD8+ lymphocytes in tumours. CONCLUSION: KEY MESSAGES: This study aimed to investigate the effect of CA on ALPPS-induced liver regeneration and hepatic tumour progression after ALPPS-induced liver regeneration. Corosolic acid inhibits tumour growth without compromising ALPPS-induced liver regeneration. This result may be attributed to the CA-induced downregulation of PD-1 and TGF-β expression and the increased CD8+ lymphocyte infiltration in tumour tissue associated with the suppression of M2 macrophage polarisation. Taylor & Francis 2022-04-28 /pmc/articles/PMC9067999/ /pubmed/35481406 http://dx.doi.org/10.1080/07853890.2022.2067893 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oncology
Zhao, Jinwei
Zhao, Weiyi
Xu, Hongyue
Luan, Wenjing
Wang, Xuefei
Fang, Yimu
Yu, Lu
Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
title Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
title_full Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
title_fullStr Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
title_full_unstemmed Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
title_short Corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
title_sort corosolic acid inhibits tumour growth without compromising associating liver partition and portal vein ligation-induced liver regeneration in rats
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067999/
https://www.ncbi.nlm.nih.gov/pubmed/35481406
http://dx.doi.org/10.1080/07853890.2022.2067893
work_keys_str_mv AT zhaojinwei corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats
AT zhaoweiyi corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats
AT xuhongyue corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats
AT luanwenjing corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats
AT wangxuefei corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats
AT fangyimu corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats
AT yulu corosolicacidinhibitstumourgrowthwithoutcompromisingassociatingliverpartitionandportalveinligationinducedliverregenerationinrats